Insider Buying: Cryosite Limited (ASX:CTE) Insider Purchases 1,000,000 Shares of Stock

Cryosite Limited (ASX:CTE) insider Mark Kerr purchased 1,000,000 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were purchased at an average cost of A$0.83 ($0.55) per share, for a total transaction of A$830,000.00 ($546,052.63).

Cryosite Stock Performance

The company has a quick ratio of 1.76, a current ratio of 2.32 and a debt-to-equity ratio of 87.26.

About Cryosite

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries.